Alkermes (ALKS) Enterprise Value (2010 - 2026)
Alkermes (ALKS) posted quarterly Enterprise Value of -$656.6 million for Q2 2026, up 35.36% year-over-year from -$485.1 million in Q2 2025, and down 28.27% quarter-over-quarter from -$511.9 million in Q1 2026.
Alkermes (ALKS) Enterprise Value (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Enterprise Value for 17 consecutive years, with -$656.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value rose 35.36% year-over-year to -$656.6 million; the TTM figure through Jun 2026 stood at -$656.6 million (up 35.36% YoY), while the FY2025 annual figure was -$1.1 billion, down 48.97% from the prior year.
- Enterprise Value eased to -$656.6 million in Q2 2026 per ALKS's latest filing, from -$511.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$511.9 million in Q1 2026 and bottomed at -$1.1 billion in Q4 2025.
- Historically, Enterprise Value has averaged -$776.2 million across 5 years, with a median of -$762.6 million in 2023.
- Annual changes were most pronounced in 2023 — Enterprise Value sank 53.25% — and 2026, when it surged 42.1%.
- Alkermes' Enterprise Value stood at -$608.5 million in 2022, then fell by 27.12% to -$773.5 million in 2023, then advanced by 2.82% to -$751.7 million in 2024, then plunged by 48.97% to -$1.1 billion in 2025, then jumped by 41.37% to -$656.6 million in 2026.
- Business Quant data shows ALKS's Enterprise Value at -$656.6 million in Q2 2026, -$511.9 million in Q1 2026, and -$1.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -656.58 Mn |
| Mar 31, 2026 | -511.86 Mn |
| Dec 31, 2025 | -1.12 Bn |
| Sep 30, 2025 | -1.11 Bn |
| Jun 30, 2025 | -1.02 Bn |
| Mar 31, 2025 | -884.02 Mn |
| Dec 31, 2024 | -751.67 Mn |
| Sep 30, 2024 | -908.86 Mn |
| Jun 30, 2024 | -876.12 Mn |
| Mar 31, 2024 | -745.05 Mn |
| Dec 31, 2023 | -773.49 Mn |
| Sep 30, 2023 | -889.15 Mn |
| Jun 30, 2023 | -829.05 Mn |
| Mar 31, 2023 | -600.46 Mn |
| Dec 31, 2022 | -608.47 Mn |
| Sep 30, 2022 | -580.18 Mn |
| Jun 30, 2022 | -580.97 Mn |
| Mar 31, 2022 | -528.87 Mn |
| Dec 31, 2021 | -536.31 Mn |
| Sep 30, 2021 | -560.30 Mn |